Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases nextdigitalhealth.com

1
Shrawan Kumar Shrawan Kumar 1 month ago in News 3

Shift Bioscience, a biotechnology startup using generative AI to explore how gene activation can reverse the aging process, has secured $16 million in seed funding to further develop its cell simulation AI platform.

The funding round was led by BGF, with significant contributions from Kindred Capital, F-Prime Capital, and Jonathan Milner.

Report Story

Related Stories

  1. TailorMed Secures $40M to Transform Patient Access to Care Nationwide
  2. TailorMed Secures $40M to Transform Patient Access to Care Nationwide
  3. Next Digital Health – Venture List of YouMobs
  4. Next Digital health – Blog List of YouMobs
Tags : healthhealth newshealthcarehealthcare newsHealthTechmedicalmedical newsMedTech

3 Comments

  • neldBlula November 11, 2024 08.40 am

    72 SPS should be discontinued in patients who become constipated, and repeat doses should not be given to patients who have not passed a bowel movement how to take priligy I had to go in anyway that day, and the doctor saw it was an extremely overactive corpus luteum producing fluid

    Reply 
  • priligy review members November 17, 2024 09.58 am

    Yesterday, while I was at work, my cousin stole my iphone and tested to see if it can survive a
    30 foot drop, just so she can be a youtube sensation. My
    iPad is now destroyed and she has 83 views. I know this is totally
    off topic but I had to share it with someone!

    Reply 
  • neldBlula November 18, 2024 06.10 am

    buy priligy Domont J, Salas S, Lacroix L, et al

    Reply 

Leave Your Comment